Over that time, FV is up 4.5%. Obviously, FBT and FDN have helped, but do not overlook the contributions of the First Trust Health Care AlphaDEX Fund (NYSEArca: FXH). FXH is FV’s second-largest holding at 20.3%.
With a nearly 16% weight to biotech stocks, FXH increases FV’s leverage to a biotech rebound. FV has also gotten a lift from the First Trust Consumer Discretionary AlphaDEX Fund (NYSEArca: FXD). FXD is up 4.3% year-to-date, which may not sound like much until considering that is well ahead of cap-weighted discretionary ETFs and that consumer discretionary is the worst-performing sector in the S&P 500 this year. [A Discretionary ETF to Remember]
FV’s other holding is the First Trust Consumer Staples AlphaDEX Fund (NYSEArca: FXG). FXG is up 13% year due to its 5.2% to Green Mountain Coffee (NasdaqGS: GMCR) and its exposure to the bidding war for Hillshire Brands (NYSE: HSH), among other factors.
First Trust Dorsey Wright Focus Five Fund
Table Courtesy: First Trust